Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2014 (2014), Article ID 409058, 6 pages
http://dx.doi.org/10.1155/2014/409058
Research Article

Malignant and Noninvasive Skin Tumours in Renal Transplant Recipients

1St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK
2The National Hospital for Neurology, 23 Queen Square, London WC1N 3BG, UK
3Department of Histopathology, Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, UK
4Department of Renal Medicine and Transplantation, St George’s Healthcare NHS Trust, Blackshaw Road, London SW17 0QT, UK
5International Medical University, Jalan Jalil Perkasa 19, 57000 Kuala Lumpur, Malaysia

Received 15 July 2014; Revised 28 August 2014; Accepted 30 August 2014; Published 14 September 2014

Academic Editor: Jean Kanitakis

Copyright © 2014 Christopher D. Roche et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. G. R. Sheil, “Cancer after transplantation,” World Journal of Surgery, vol. 10, no. 3, pp. 389–396, 1986. View at Publisher · View at Google Scholar · View at Scopus
  2. F. J. Moloney, H. Comber, P. O'Lorcain, P. O'Kelly, P. J. Conlon, and G. M. Murphy, “A population-based study of skin cancer incidence and prevalence in renal transplant recipients,” British Journal of Dermatology, vol. 154, no. 3, pp. 498–504, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. P. Gallagher, P. J. Kelly, M. Jardine et al., “Long-term cancer risk of immunosuppressive regimens after kidney transplantation,” Journal of the American Society of Nephrology, vol. 21, no. 5, pp. 852–858, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. B. Campbell, R. Walker, S. S. Tai, Q. Jiang, and G. R. Russ, “Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer,” The American Journal of Transplantation, vol. 12, no. 5, pp. 1146–1156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Euvrard, E. Morelon, L. Rostaing et al., “Sirolimus and secondary skin-cancer prevention in kidney transplantation,” The New England Journal of Medicine, vol. 367, no. 4, pp. 329–339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Hoogendijk-van Den Akker, P. N. Harden, A. J. Hoitsma et al., “Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus,” Journal of Clinical Oncology, vol. 31, no. 10, pp. 1317–1323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Alberú, M. D. Pascoe, J. M. Campistol et al., “Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial.,” Transplantation, vol. 92, no. 3, pp. 303–310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Morath, M. Mueller, H. Goldschmidt, V. Schwenger, G. Opelz, and M. Zeier, “Malignancy in renal transplantation,” Journal of the American Society of Nephrology, vol. 15, no. 6, pp. 1582–1588, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Jensen, S. Hansen, B. Moller et al., “Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens,” Journal of the American Academy of Dermatology, vol. 40, no. 2, pp. 177–186, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. J. N. Bouwes Bavinck, D. R. Hardie, A. Green et al., “The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study,” Transplantation, vol. 61, no. 5, pp. 715–721, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Bordea, F. Wojnarowska, P. R. Millard, H. Doll, K. Welsh, and P. J. Morris, “Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate,” Transplantation, vol. 77, no. 4, pp. 574–579, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Blohme and O. Larkö, “Premalignant and malignant skin lesions in renal transplant patients,” Transplantation, vol. 37, no. 2, pp. 165–167, 1984. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Birkeland, H. H. Storm, L. U. Lamm et al., “Cancer risk after renal transplantation in the nordic countries, 1964–1986,” International Journal of Cancer, vol. 60, no. 2, pp. 183–189, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Hartevelt, J. N. Bouwes Bavinck, A. M. Kootte m., B. J. Vermeer, and J. P. Vandenbroucke, “Incidence of skin cancer after renal transplantation in the Netherlands,” Transplantation, vol. 49, no. 3, pp. 506–509, 1990. View at Publisher · View at Google Scholar · View at Scopus
  15. H. M. Ramsay, A. A. Fryer, C. M. Hawley, A. G. Smith, D. L. Nicol, and P. N. Harden, “Non-melanoma skin cancer risk in the Queensland renal transplant population,” British Journal of Dermatology, vol. 147, no. 5, pp. 950–956, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Liddington, A. J. Richardson, R. M. Higgins et al., “Skin cancer in renal transplant recipients,” British Journal of Surgery, vol. 76, no. 10, pp. 1002–1005, 1989. View at Publisher · View at Google Scholar · View at Scopus
  17. M. T. Glover, N. Niranjan, J. T. C. Kwan, and I. M. Leigh, “Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management,” British Journal of Plastic Surgery, vol. 47, no. 2, pp. 80–89, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. P. N. Harden, S. M. Reece, A. A. Fryer, A. G. Smith, and H. M. Ramsay, “Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice,” British Medical Journal, vol. 323, no. 7313, pp. 600–601, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. E. W. Cowen and E. M. Billingsley, “Awareness of skin cancer by kidney transplant patients,” Journal of the American Academy of Dermatology, vol. 40, no. 5 I, pp. 697–701, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. H. M. Ramsay, S. M. Reece, A. A. Fryer, A. G. Smith, and P. N. Harden, “Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients,” Transplantation, vol. 84, no. 3, pp. 437–439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. B. L. Kasiske, M. A. Vazquez, W. E. Harmon et al., “Recommendations for the outpatient surveillance of renal transplant recipients,” Journal of the American Society of Nephrology, vol. 11, no. 15, pp. S1–S86, 2000. View at Google Scholar · View at Scopus
  22. I. R. Hardie, R. W. Strong, L. C. J. Hartley, P. W. H. Woodruff, and G. J. A. Clunie, “Skin cancer in Caucasian renal allograft recipients living in a subtropical climate,” Surgery, vol. 87, no. 2, pp. 177–183, 1980. View at Google Scholar · View at Scopus
  23. A. Lomas, J. Leonardi-Bee, and F. Bath-Hextall, “A systematic review of worldwide incidence of nonmelanoma skin cancer,” British Journal of Dermatology, vol. 166, no. 5, pp. 1069–1080, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. L. J. Christenson, T. A. Borrowman, C. M. Vachon et al., “Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years,” Journal of the American Medical Association, vol. 294, no. 6, pp. 681–690, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Mork, A. K. Lie, E. Glattre et al., “Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck,” The New England Journal of Medicine, vol. 344, no. 15, pp. 1125–1131, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Syrjanen, “Human papillomavirus infections and oral tumours,” Medical Microbiology and Immunology, vol. 192, no. 3, pp. 123–128, 2003. View at Publisher · View at Google Scholar
  27. M. L. Gillison, “Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers,” Journal of Clinical Oncology, vol. 24, no. 36, pp. 5623–5625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Berg and C. C. Otley, “Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management,” Journal of the American Academy of Dermatology, vol. 47, no. 1, pp. 1–17, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Dreno, “Skin cancers after transplantation,” Nephrology Dialysis Transplantation, vol. 18, no. 6, pp. 1052–1058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Kuijken and J. N. B. Bavinck, “Skin cancer risk associated with immunosuppressive therapy in organ transplant recipients: epidemiology and proposed mechanisms,” BioDrugs, vol. 14, no. 5, pp. 319–329, 2000. View at Publisher · View at Google Scholar · View at Scopus